Lilit Grigoryan,Yupeng Feng,Lorenza Bellusci,Lilin Lai,Bushra Wali,Madison Ellis,Meng Yuan,Prabhu S Arunachalam,Mengyun Hu,Sangeeta Kowli,Sheena Gupta,Sofia Maysel-Auslender,Holden T Maecker,Hady Samaha,Nadine Rouphael,Ian A Wilson,Alberto C Moreno,Mehul S Suthar,Surender Khurana,Stéphane Pillet,Nathalie Charland,Brian J Ward,Bali Pulendran,Prabhu S. Arunachalam,Holden T. Maecker,Ian A. Wilson,Alberto C. Moreno,Mehul S. Suthar,Brian J. Ward

Abstract:Vaccine adjuvants increase the breadth of serum antibody responses, but whether this is due to the generation of antigen-specific B cell clones with distinct specificities or the maturation of memory B cell clones that produce broadly cross-reactive antibodies is unknown. Here, we longitudinally analyzed immune responses in healthy adults after two-dose vaccination with either a virus-like particle COVID-19 vaccine (CoVLP), CoVLP adjuvanted with AS03 (CoVLP+AS03), or a messenger RNA vaccination (mRNA-1273). CoVLP+AS03 enhanced the magnitude and durability of circulating antibodies and antigen-specific CD4 + T cell and memory B cell responses. Antigen-specific CD4 + T cells in the CoVLP+AS03 group at day 42 correlated with antigen-specific memory B cells at 6 months. CoVLP+AS03 induced memory B cell responses, which accumulated somatic hypermutations over 6 months, resulting in enhanced neutralization breadth of monoclonal antibodies. Furthermore, the fraction of broadly neutralizing antibodies encoded by memory B cells increased between day 42 and 6 months. These results indicate that AS03 enhances the antigenic breadth of B cell memory at the clonal level and induces progressive maturation of the B cell response.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore whether the AS03 adjuvant can enhance the breadth, durability and clonal diversity of the memory B - cell responses induced by the plant - based COVID - 19 vaccine (CoVLP) in the human body. Specifically, by comparing the immune responses of people vaccinated with different vaccine formulations (non - adjuvant CoVLP, AS03 - adjuvant CoVLP and mRNA - 1273 vaccine), the researchers evaluated the impact of the AS03 adjuvant on the following aspects: 1. **Serum antibody response**: The researchers measured the binding antibody titers against the wild - type (WT) of SARS - CoV - 2 and its various variants in the sera of the subjects to evaluate whether the AS03 adjuvant can improve the level and breadth of antibodies. 2. **Memory B - cell response**: By analyzing the frequency of antigen - specific memory B - cells in peripheral blood mononuclear cells (PBMCs) through flow cytometry, the researchers evaluated the impact of the AS03 adjuvant on the memory B - cell response, especially the cumulative somatic hypermutation (SHMs) of these cells. 3. **T - cell response**: Through intracellular cytokine staining (ICS) experiments, the researchers analyzed the CD4+ T - cell responses of the subjects, especially the production of helper T - cell 1 (Th1) and Th2 - type cytokines, to understand the impact of the AS03 adjuvant on the T - cell response and explore the correlation between the T - cell response and the memory B - cell response. 4. **Breadth of monoclonal antibodies**: The researchers generated monoclonal antibodies (mAbs) from isolated memory B - cells and evaluated whether the AS03 adjuvant can enhance the breadth of antibodies by detecting the binding ability of these mAbs to the wild - type of SARS - CoV - 2 and its variants. In summary, this paper aims to systematically compare the effects of different vaccine formulations to reveal how the AS03 adjuvant affects the human immune response to the plant - based COVID - 19 vaccine, especially its role in the breadth and durability of the memory B - cell response.

AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans

Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans

An innate immune signature induced by AS01- or AS03-adjuvanted vaccines predicts the antibody response magnitude and quality consistently over time

Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination

A Third Dose of Inactivated Vaccine Augments the Potency, Breadth, and Duration of Anamnestic Responses Against SARS-CoV-2

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

Functional and epigenetic changes in monocytes from adults immunized with an AS01-adjuvanted vaccine

Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination

Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines

An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice

A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2.

Adjuvant activities of immunostimulating natural products: Astragalus membranaceus (Fisch.) Bge. and Coriolus versicolor in BNT162b2 vaccination against COVID-19 infection

Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine

Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates

Early human B cell signatures of the primary antibody response to mRNA vaccination

Comparison of Antigen-Specific B Cell Responses Reveals Disparity in Immunogenicity and Memory B Cell Formation Across COVID-19 Vaccine Platforms

Acute and persistent responses after H5N1 vaccination in humans

Vaccines combining slow delivery and follicle targeting of antigens increase germinal center B cell clonal diversity and clonal expansion

Specific long-term changes in anti-SARS-CoV-2 IgG modifications and antibody functions in mRNA, adenovector, and protein subunit vaccines

Dose-dependent regulation of immune memory responses against HIV by saponin monophosphoryl lipid A nanoparticle adjuvant